Crossref
Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma
Integrative Cancer Science and Therapeutics · 2015
DOI: 10.15761/icst.1000118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Cancer Science and Therapeutics, 2015.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2015). Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma. Integrative Cancer Science and Therapeutics. https://doi.org/10.15761/icst.1000118
Vancouver
Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma. Integrative Cancer Science and Therapeutics. 2015. doi:10.15761/icst.1000118
BibTeX
@article{euvimed2015,
title = {Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma},
journal = {Integrative Cancer Science and Therapeutics},
year = {2015},
doi = {10.15761/icst.1000118}
}
EUVIMED